在COVID-19疫苗接种后,IgA血管炎和炎的首次出现
Jesús Iván Martínez-Ortega1, Felipe Perez-Hernandez2, Ilse Fernández-Reyna3
1Department of Dermatology, Dermatological Institute of Jalisco "Dr. José Barba Rubio", Zapopan, MEX.
Cureus
|August 28, 2023
概括
在AstraZeneca的COVID-19疫苗接种后发生了一例罕见的IgA血管炎炎 (IgAVN). 医疗保健提供者必须认识到这种潜在的不良事件,尽管疫苗的好处超过了风险.
科学领域:
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學.
- 疫苗学 疫苗学 疫苗学
背景情况:
- COVID-19疫苗在减少严重疾病和死亡率方面显示出显著的好处.
- 虽然免疫接种通常是安全的,但免疫接种后的罕见不良事件 (AEFI) 可能会发生.
- IgA血管炎 (IgAV) 是一种以IgA沉积为特征的全身性血管炎.
研究的目的:
- 报告发生在COVID-19疫苗接种后的IgA血管炎炎 (IgAVN) 病例.
- 提高医疗保健提供者对潜在的罕见疫苗相关不良事件的认识.
- 强调及时诊断和IgAVN.管理的重要性.
主要方法:
- 案例报告的呈现方式.
- 对临床表现,诊断结果和治疗的审查.
- 讨论潜在的病理机制和文献综述.
主要成果:
- 一名32岁的男性在接种第二剂AstraZeneca COVID-19疫苗后出现IgA血管炎 (IgAV) 和IgA血管炎炎 (IgAVN).
- 患者的病情需要医疗干预和监测.
- 这一案例强调了IgAVN作为与COVID-19疫苗相关的潜在,尽管罕见的不良事件.
结论:
- IgA血管炎炎 (IgAVN) 是一种罕见但在接种COVID-19疫苗后被认可的潜在不良事件.
- 对于受影响的个体来说,迅速识别和管理至关重要.
- 接种COVID-19疫苗的公共卫生益处明显超过了像IgAVN这样的罕见不良事件的风险.
更多相关视频
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
1.8K
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11.5K
相关概念视频
01:29Acute Kidney Injury III: Clinical Manifestations
29
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
29
01:27Allergic Drug Reactions
875
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
875
01:14Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
34
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
34
01:27Acute Pyelonephritis I: Introduction
21
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
21
01:25Endocarditis II: Clinical Features of Infective Endocarditis
14
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
14